Info
Significant Ownership

Significant Ownership of Baselake Partners, LP

Signature - Title: /s/ David Paolella - David Paolella, Managing Member of Baselake Management, LLC, its investment manager
Location: Troy, MI
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Baselake Partners, LP.

Notify me when Baselake Partners, LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Baselake Partners, LP

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
NEUP	Neuphoria Therapeutics Inc.	Common Stock, $0.00001 par value per share	9.4%	$2,635,553		222,222		Baselake Partners, LP	27 Oct 2025
ATHA	Athira Pharma, Inc.	Common Stock, $0.0001 par value per share	5%	$817,216		197,481		Baselake Partners, LP	07 Nov 2025

Schedules 13D/G Reported by Baselake Partners, LP:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Filing Date

* An asterisk sign (*) next to the price indicates that the price is likely invalid.